Free Newsletter
Chinese institute collaborates on 3G sequencing tech
A Chinese newspaper reports that the Inspur Group is teaming up with a genomics institute at the Chinese Academy of Sciences to develop a third-generation genome sequencing technology that can cut as much as 99 percent off the price of new sequencing projects.
Second-gen sequencing technology has cut the cost of the work to the $60,000 to $100,000 range, but the tech collaboration in China will pursue the Holy Grail of tech developers: A $1,000 sequencing tab. And it's planning to release the first test instrument in 2013. Inspur supplies computing platforms and IT applications in China.
"The home-made third-generation genome sequencing instrument is not only conducive to life science research, but also concerns the genetic safety of China," said Yu Jun, deputy head of the Beijing Institute of Genomics with the Chinese Academy of Sciences.
- here's the report from Xinhua
Related Articles:
Knome unveils new sequencing service
Pacific Biosciences gains $100M for sequencing tech
Breast cancer breakthrough spotlights sequencing impact
Pacific Biosciences plans 15-minute sequencing feat
Sequencing cost slides to $4400 at Complete Genomics
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: